Scaled-back Alibaba settlement reflects DOJ's approach to food and drug cases
For eight years, Chinese online retailer Alibaba and its U.S. payment processing company failed to prevent dangerous drugs, chemicals and pill presses from being sold to American customers — even after employees warned of compliance problems, public …